India is experiencing a significant change in healthcare towards personalized and precision medicine due to the advancements in molecular testing technologies. This change is leading to new possibilities in disease diagnosis, treatment selection, and patient care. With the biotechnology industry growing at a rate of
POST TAGS:
artificial intelligence (AI)biotechnology industrycirculating tumor DNA (ctDNA)clinical exome testingCORE DiagnosticsDr. Shivani Sharmaendocrine therapiesmachine learning (ML)Molecular Testingnext-generation sequencing (NGS)OncologyPathology Services and Labpolymerase chain reaction (PCR)trastuzumabWhole exome sequencing (WES)